Therefore, B2-OKT3 BiTE can target MICA on tumor cells and CD3ε on T cells through the tandem scFv BiTE format, which specifically induces T cells to kill tumor cells (Godbersen et al., 2017) (Figure 3). Here, MICA is linked to neoplasm.